Omeros Corp. (OMER)
12.04
+0.03
(+0.25%)
USD |
NASDAQ |
Feb 20, 16:00
12.05
+0.01
(+0.08%)
After-Hours: 20:00
Omeros SG&A Expense (Quarterly) : 10.40M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Edgewise Therapeutics, Inc. | 9.378M |
| Dynavax Technologies Corp. (DELISTED) | 40.09M |
| Gilead Sciences, Inc. | 1.794B |
| Merck & Co., Inc. | 2.898B |
| REGENXBIO, Inc. | 20.25M |